FDA Inspection 615187 — Tayca Corporation
The FDA completed an inspection of Tayca Corporation on Aug 27, 2009 in Okayama. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 27, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Okayama (Japan)